本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amylyx Pharmaceuticals

14.86
+0.75005.32%
成交量:29.01萬
成交額:417.33萬
市值:16.43億
市盈率:-8.38
高:14.92
開:14.07
低:13.92
收:14.11
52周最高:17.49
52周最低:2.60
股本:1.11億
流通股本:6,544.94萬
量比:0.74
換手率:0.44%
股息:- -
股息率:- -
每股收益(TTM):-1.7742
每股收益(LYR):-4.4281
淨資產收益率:-56.52%
總資產收益率:-39.44%
市淨率:4.95
市盈率(LYR):-3.36

資料載入中...

2026/03/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/03

重要事件披露

Form 8-K - Current report
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities